Citrus Sinensis ID: 003328


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------83
MFNIPNVADVEKKMEETIRKDPIAISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNSETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLEMMVGPDREKPTTSLGFNEITADDDAAPKVGIPGILVNLNVSRCDKIEEIIRHVGEEVKENRIAFGKLKVLILNYLPTLTSFCLENYTLEFPSLERVSLTHCPNMKTFSHRILSIPKPCKVQVTEKEEGELHHWEGNNLNSTIQKCYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLHLEELNADKEHIGPLFLELSLLGLIDLPKLKRFCNFTGNIIEMPVLCSLAIENCTDMETFISNSVVHATTDNKEPQKLTSEENFLLVHQVQPLFNEKVGEEAKDCIVFRELEYLTLDCLPSLTSFSLGNYALEFPSLEHVVVRQCPTMKIFSQGGVDAPKLNKVKPTEEEDGDEVDDDDDDEEGCWEGNLNDTIKKLFNEMVSINEVLALSSKLFL
ccccccccccccccccccccccEEEEcccccccccccccccccccEEEccccccccccccccHHHHcccccccEEEccccccccccccccccccccEEEcccccccccccccccccccEEEEcccccccccccccccccccEEEccccccccEEccccccccccccEEEccccccccccccccccccHHHccccccccEEEEEEcccccccccccccccccEEEEEcccccccccccccccEEEEcccccccccccccHHHHccccccEEEEEccccccccccccccccccccccEEEEccccccEEEcccccccccccccccccEEcccccccHHccccccccccccccccEEEEEcccccccccccccccccccccEEEEEccccccccccccccccccccccccccccccccccccccccccEEEEcccccHHHHHHHHcccccccccccccccEEEcccccccccccccccccccccccEEEEEccccccccccccccccccccEEEccccccccccccccccccHHHHHcccccccccccEEEEccccccccccccccccccccccccEEEEEEccccccccccccccccccccEEEEEccccccEEcccccccccccccccccccccEEEccccccccccccccccccccccccEEEEEcccccccccccccccccccccccccccccHHHHHHcccccccccccccccccccccccccEEEcccccccccccccccccccccccEEEEEcccccccccccccccccccEEEcccccccccccccccccccccccccHHHHHHHHHHHHccccEEcccccccc
ccEEccccccccccccccccccEEEEEEcccHHHccccccccccEEEEEEEcccccccccccHHHHHcccccEEEEcccccccccccHHHHHHcccEEEcccccccccHHHHHHcccEEEEEcccccHcccHHHHHcccccEEEccccccccEccHHHHHHHHHHcEEEEcccccccccccccccccHHHHHHcccccEEEEEcccccccccccccHHHEEEEEEccccccccccccccccHHHHcccccccccccccccHHHHccccEEEEccccccccccccccHccccccccEEEEcccccEEEcccccccccccccccccEEEcccHHHHHHHcccccccccccccccEEEEccccccccccccHHHHccHcccEEEEcccccHHHHcccccccccHHHHHHHcccccccccccccccccccccEEccccHHHHHccccccccccccccccccEEEEcccccHcHccccccccccccccEEEEEccccEEEcccccccccHccEEEEEcccHHHHHHHHHcccccccccccccccccccccEEEEcccccHHHcccccccccccccccEEEEEEccccccEccccHHHHHHHcccEEEEcccccHHHHHccccccccccccccccHHEEHHcccccccHHcHccccccccccccccEEEEEcccccHHcccccHHHHHcccHHccEEEEcccHcHHEEEEccccccccccccccEEcccccEEEEccccccccccccccccccccccEEEEEcccccEEcccccccccccEEEEEEccccccEcccccccccccccccHHHHHHHHHHHcccccccccccccccc
MFNIPNVADVEKKMEETIrkdpiaislpqrdiqelperlqcpnlQLFLLITkgiapvsmqISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILsfrgsdikqlpleigqltrlqlldlsncsslvviapnviskfsrleelymgdsfsqwdkveggsnaslaelkglsklttlEIHVwdaqilpqdwvSVELQRYKICigearriwpvnsetSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNvvhelddgegfprlKHLWVERCSEILHIVGsvgrvrctIFPLLESLSLWFLSNLETICdsqltedqsfsnlriIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFfcddlemmvgpdrekpttslgfneitadddaapkvgipgilvnlnvsrcDKIEEIIRHVGEEVKENRIAFGKLKVLILNYLptltsfclenytlefpslervslthcpnmktfshrilsipkpckvqvtekeegelhhwegnnlnSTIQKCYEEMIgfrdiehlqlshfprlreiwhgqalpvsffnnlsdlvvddctnmssaipanLLRCFNNLVLlevrncdsleevlhleelnadkehigPLFLELSllglidlpklkrfcnftgniiemPVLCSLAIENCTDMETFISNSVvhattdnkepqkltseENFLLVHQVQplfnekvgeeakDCIVFRELEyltldclpsltsfslgnyalefpslehvvvrqcptmkifsqggvdapklnkvkpteeedgdevddddddeegcwegnLNDTIKKLFNEMVSINEVLALSSKLFL
mfnipnvadveKKMEetirkdpiaislPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICigearriwpvnsETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLEMMVGPDREKPTTSLGFNEITADDDAAPKVGIPGIlvnlnvsrcDKIEEIIrhvgeevkenriafGKLKVLILNYLPTLTSFCLENYTLEFPSLERVSLTHCPNMKTFshrilsipkpCKVQVTEKEEgelhhwegnnlnSTIQKCYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLHLEELNADKEHIGPLFLELSLLGLIDLPKLKRFCNFTGNIIEMPVLCSLAIENCTDMETFISNSVVHATTDNKEPQKLTSEENFLLVHQVQPLFNEKVGEEAKDCIVFRELEYLTLDCLPSLTSFSLGNYALEFPSLEHVVVRQCPTMKifsqggvdapklnkvkpteeedgdevddddddeegCWEGNLNDTIKKLFNEMVSINEVLALSSKLFL
MFNIPNVADVEKKMEETIRKDPIAISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNSETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLEMMVGPDREKPTTSLGFNEITADDDAAPKVGIPGILVNLNVSRCDKIEEIIRHVGEEVKENRIAFGKLKVLILNYLPTLTSFCLENYTLEFPSLERVSLTHCPNMKTFSHRILSIPKPCKVQVTEKEEGELHHWEGNNLNSTIQKCYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLHLEELNADKEHIGPlflelsllglidlPKLKRFCNFTGNIIEMPVLCSLAIENCTDMETFISNSVVHATTDNKEPQKLTSEENFLLVHQVQPLFNEKVGEEAKDCIVFRELEYLTLDCLPSLTSFSLGNYALEFPSLEHVVVRQCPTMKIFSQGGVDAPKLNKVKPTeeedgdevddddddeegCWEGNLNDTIKKLFNEMVSINEVLALSSKLFL
*******************************IQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNSETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLT*********************LFSFSMAKNLLRLQKVEVFFCDDLEMMVG*********LGFNEITADDDAAPKVGIPGILVNLNVSRCDKIEEIIRHVGEEVKENRIAFGKLKVLILNYLPTLTSFCLENYTLEFPSLERVSLTHCPNMKTFSHRILSIPKPCKVQVTEKEEGELHHWEGNNLNSTIQKCYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLHLEELNADKEHIGPLFLELSLLGLIDLPKLKRFCNFTGNIIEMPVLCSLAIENCTDMETFISNSVVHA*************ENFLLVHQVQPLFNEKVGEEAKDCIVFRELEYLTLDCLPSLTSFSLGNYALEFPSLEHVVVRQCPTMKIFSQG******************************CWEGNLNDTIKKLFNEMVSINEVLAL******
MFNI***ADVEKKMEETIRKDPIAISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSL*********KFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNSETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLEMMVGP**********FNEIT**************LVNLNVSRCDKIEEI***********RIAFGKLKVLILNYLPTLTSFCLENYTLEFPSLERVSLTHCPNMKTFSHRIL***KP**VQVTEKEEGELHHWEGNNLNSTIQKCYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLHLE************FLELSLLGLIDLPKLKRFCNFTGNIIEMPVLCSLAIENCTDMETFISN*V************L*SE***L********************IVFRELEYLTLDCLPSLTSFSLGNYALEFPSLEHVVVRQCPTMKI*S***********VKPTEEEDGDEVDDDDDDEEGCWEGNLNDTIKKLFNEMVSINEVLALSSKLFL
MFNIPNVADVEKKMEETIRKDPIAISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNSETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLEMMVGPDREKPTTSLGFNEITADDDAAPKVGIPGILVNLNVSRCDKIEEIIRHVGEEVKENRIAFGKLKVLILNYLPTLTSFCLENYTLEFPSLERVSLTHCPNMKTFSHRILSIPKPCKVQVTEKEEGELHHWEGNNLNSTIQKCYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLHLEELNADKEHIGPLFLELSLLGLIDLPKLKRFCNFTGNIIEMPVLCSLAIENCTDMETFISNSVVHATTDNKEPQKLTSEENFLLVHQVQPLFNEKVGEEAKDCIVFRELEYLTLDCLPSLTSFSLGNYALEFPSLEHVVVRQCPTMKIFSQGGVDAPKLNKV******************EGCWEGNLNDTIKKLFNEMVSINEVLALSSKLFL
MFNIPNVADVEKKMEETIRKDPIAISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNSETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLEMMVGPDREKPTTSLGFNEITADDDAAPKVGIPGILVNLNVSRCDKIEEIIRHVGEEVKENRIAFGKLKVLILNYLPTLTSFCLENYTLEFPSLERVSLTHCPNMKTFSHRILSIPKPCKVQVTEKEEGELHHWEGNNLNSTIQKCYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLHLEELNADKEHIGPLFLELSLLGLIDLPKLKRFCNFTGNIIEMPVLCSLAIENCTDMETFISNSVVHATTDNKEPQKLTSEENFLLVHQVQPLFN*****EAKDCIVFRELEYLTLDCLPSLTSFSLGNYALEFPSLEHVVVRQCPTMKIFSQGGVDAPKLNKVKPTEEEDGDEVDDDDDDEEGCWEGNLNDTIKKLFNEMVSINEVLALSSKLFL
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MFNIPNVADVEKKMEETIRKDPIAISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNSETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLEMMVGPDREKPTTSLGFNEITADDDAAPKVGIPGILVNLNVSRCDKIEEIIRHVGEEVKENRIAFGKLKVLILNYLPTLTSFCLENYTLEFPSLERVSLTHCPNMKTFSHRILSIPKPCKVQVTEKEEGELHHWEGNNLNSTIQKCYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLHLEELNADKEHIGPLFLELSLLGLIDLPKLKRFCNFTGNIIEMPVLCSLAIENCTDMETFISNSVVHATTDNKEPQKLTSEENFLLVHQVQPLFNEKVGEEAKDCIVFRELEYLTLDCLPSLTSFSLGNYALEFPSLEHVVVRQCPTMKIFSQGGVDAPKLNKVKPTEEEDGDEVDDDDDDEEGCWEGNLNDTIKKLFNEMVSINEVLALSSKLFL
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query829 2.2.26 [Sep-21-2011]
Q9T048985 Disease resistance protei yes no 0.439 0.369 0.270 2e-18
O81825919 Probable disease resistan no no 0.480 0.433 0.246 1e-14
Q42484909 Disease resistance protei no no 0.436 0.398 0.230 1e-12
Q96RT1 1412 Protein LAP2 OS=Homo sapi no no 0.164 0.096 0.324 5e-06
Q80TH2 1402 Protein LAP2 OS=Mus muscu yes no 0.164 0.097 0.324 5e-06
Q9LRR41054 Putative disease resistan no no 0.371 0.292 0.236 6e-05
Q5F4C4529 Leucine-rich repeat prote no no 0.133 0.209 0.336 0.0001
C0LGP41010 Probable LRR receptor-lik no no 0.166 0.136 0.335 0.0002
Q96CX6371 Leucine-rich repeat-conta no no 0.125 0.280 0.355 0.0003
Q6UWE0723 E3 ubiquitin-protein liga no no 0.166 0.190 0.290 0.0003
>sp|Q9T048|DRL27_ARATH Disease resistance protein At4g27190 OS=Arabidopsis thaliana GN=At4g27190 PE=2 SV=1 Back     alignment and function desciption
 Score = 95.1 bits (235), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 107/395 (27%), Positives = 188/395 (47%), Gaps = 31/395 (7%)

Query: 16  ETIRKDPIA-----ISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTE 70
           + IR+D +A     +SL    ++ LP+ ++   ++  +L+ +G   +  ++   F +   
Sbjct: 492 QDIRQDKLAPSLRRVSLMNNKLESLPDLVEEFCVKTSVLLLQGNFLLK-EVPIGFLQAFP 550

Query: 71  ELKVLSLIGIHFSSLPS-SLGRLINLQTLCLDWC-QLEDVAAIGQLKKLEILSFRGSDIK 128
            L++L+L G    S PS SL RL +L +L L  C +L  + ++  L KLE+L   G+ I 
Sbjct: 551 TLRILNLSGTRIKSFPSCSLLRLFSLHSLFLRDCFKLVKLPSLETLAKLELLDLCGTHIL 610

Query: 129 QLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGS---N 185
           + P  + +L R + LDLS    L  I   V+S+ S LE L M  S  +W  V+G +    
Sbjct: 611 EFPRGLEELKRFRHLDLSRTLHLESIPARVVSRLSSLETLDMTSSHYRWS-VQGETQKGQ 669

Query: 186 ASLAELKGLSKLTTLEIHVWDAQIL---PQDWVSVELQRYKICIGEARRIWPVNSETSRL 242
           A++ E+  L +L  L I +  +  L      W+   L+++++ +G +R I     +  RL
Sbjct: 670 ATVEEIGCLQRLQVLSIRLHSSPFLLNKRNTWIK-RLKKFQLVVG-SRYILRTRHDKRRL 727

Query: 243 VWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHEL-DDGEGFPRLKHLWVER 301
              H   NVS +     +  LL     + L   +G++ ++ +L  D +GF  LK L +E 
Sbjct: 728 TISHL--NVSQV----SIGWLLAYTTSLALNHCQGIEAMMKKLVSDNKGFKNLKSLTIEN 781

Query: 302 C-----SEILHIVGSVGRVRCTIFPLLESLSLWFLS--NLETICDSQLTEDQSFSNLRII 354
                 S +  +  +  +    I  LL +L    L   +LET  + Q         L+II
Sbjct: 782 VIINTNSWVEMVSTNTSKQSSDILDLLPNLEELHLRRVDLETFSELQTHLGLKLETLKII 841

Query: 355 EVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLE 389
           E+  C KL+ L        +  L+++E+ +CD L+
Sbjct: 842 EITMCRKLRTLLDKRNFLTIPNLEEIEISYCDSLQ 876




Disease resistance protein.
Arabidopsis thaliana (taxid: 3702)
>sp|O81825|DRL28_ARATH Probable disease resistance protein At4g27220 OS=Arabidopsis thaliana GN=At4g27220 PE=2 SV=1 Back     alignment and function description
>sp|Q42484|RPS2_ARATH Disease resistance protein RPS2 OS=Arabidopsis thaliana GN=RPS2 PE=1 SV=1 Back     alignment and function description
>sp|Q96RT1|LAP2_HUMAN Protein LAP2 OS=Homo sapiens GN=ERBB2IP PE=1 SV=2 Back     alignment and function description
>sp|Q80TH2|LAP2_MOUSE Protein LAP2 OS=Mus musculus GN=Erbb2ip PE=1 SV=3 Back     alignment and function description
>sp|Q9LRR4|R13L1_ARATH Putative disease resistance RPP13-like protein 1 OS=Arabidopsis thaliana GN=RPPL1 PE=3 SV=1 Back     alignment and function description
>sp|Q5F4C4|SHOC2_CHICK Leucine-rich repeat protein SHOC-2 OS=Gallus gallus GN=SHOC2 PE=2 SV=1 Back     alignment and function description
>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 Back     alignment and function description
>sp|Q96CX6|LRC58_HUMAN Leucine-rich repeat-containing protein 58 OS=Homo sapiens GN=LRRC58 PE=1 SV=2 Back     alignment and function description
>sp|Q6UWE0|LRSM1_HUMAN E3 ubiquitin-protein ligase LRSAM1 OS=Homo sapiens GN=LRSAM1 PE=1 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query829
255563252 1603 Disease resistance protein RPS5, putativ 0.749 0.387 0.376 1e-96
224111296 1315 cc-nbs-lrr resistance protein [Populus t 0.686 0.432 0.388 8e-96
359488288 1340 PREDICTED: LOW QUALITY PROTEIN: probable 0.849 0.525 0.349 7e-92
255542484 2460 phosphoprotein phosphatase, putative [Ri 0.889 0.299 0.335 9e-92
359488027 1520 PREDICTED: disease resistance protein At 0.804 0.438 0.344 3e-90
255574526 1232 Disease resistance protein RFL1, putativ 0.846 0.569 0.331 4e-89
224111284 1340 cc-nbs-lrr resistance protein [Populus t 0.675 0.417 0.385 4e-88
224110992 2359 cc-nbs-lrr resistance protein [Populus t 0.715 0.251 0.374 2e-86
224143316 1337 cc-nbs-lrr resistance protein [Populus t 0.675 0.418 0.377 5e-84
296087872 1152 unnamed protein product [Vitis vinifera] 0.746 0.537 0.348 1e-81
>gi|255563252|ref|XP_002522629.1| Disease resistance protein RPS5, putative [Ricinus communis] gi|223538105|gb|EEF39716.1| Disease resistance protein RPS5, putative [Ricinus communis] Back     alignment and taxonomy information
 Score =  360 bits (925), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 271/719 (37%), Positives = 389/719 (54%), Gaps = 98/719 (13%)

Query: 1    MFNIPNVADVEKKMEETIRKDPIAISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQ 60
            +F + N A +++   + + K    ISLP  DI  LPE L+CP L+LFLL T+ I   S++
Sbjct: 484  LFTVRNGALLKEWPNKDVCKSCTRISLPYNDIHGLPEVLECPELELFLLFTQDI---SLK 540

Query: 61   ISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEIL 120
            + DL FE T+ L+VL+  G+HFSSLP SLG L NL TLCLDWC L DVA IG+L  L IL
Sbjct: 541  VPDLCFELTKNLRVLNFTGMHFSSLPPSLGFLKNLFTLCLDWCALRDVAIIGELTGLTIL 600

Query: 121  SFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWD-- 178
            SF+ SDI +LP EI QLT+L+ LDLS+C  L VI   +IS+ ++LEELYM +SF  WD  
Sbjct: 601  SFKHSDIVELPREIRQLTKLKFLDLSHCLKLKVIPAKIISELTQLEELYMNNSFDLWDVQ 660

Query: 179  KVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNSE 238
             +    NASLAEL+ L  LTTLEI V DA+ILP+D    +L+R++I IG+   +W    +
Sbjct: 661  GINNQRNASLAELECLPYLTTLEICVLDAKILPKDLFFRKLERFRIFIGD---VWSGTGD 717

Query: 239  --TSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKH 296
              TSR + L    N S++   +G+ +LL+  E+++L ++KG+++V+++LD  +GF +LKH
Sbjct: 718  YGTSRTLKLK--LNTSSIHLEHGLSILLEVTEDLYLAEVKGIKSVLYDLD-SQGFTQLKH 774

Query: 297  LWVERCSEILHIVGSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEV 356
            L V+   EI +I+    R  C  FP+LESL L  L +LE IC  +LT   SFS LR + V
Sbjct: 775  LDVQNDPEIQYIIDPNRRSPCNAFPILESLYLDNLMSLEKICCGKLTTG-SFSKLRSLTV 833

Query: 357  KSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLEMMVGPDREKPTTSLGFNEITADDDAAP 416
              CD+LK+LFSFSM + LL+LQ+++V                                  
Sbjct: 834  VKCDRLKNLFSFSMMRCLLQLQQMKVV--------------------------------- 860

Query: 417  KVGIPGILVNLNVSRCDKIEEIIRHVGEEVKEN---RIAFGKLKVLILNYLPTLTSFCLE 473
                           C  +EEI+   G E  +N    +   +L  L L  LP   SFC +
Sbjct: 861  --------------DCANLEEIV-ACGSEDTDNDYEAVKLTQLCSLTLKRLPMFKSFCSK 905

Query: 474  NYTLEFPSLERVSLTHCPNMKTFSHRILSIPKPCKVQVTEKEEGELHHWEGNNLNSTIQK 533
                      +  LT    +K  +      PK           GEL    G+ L      
Sbjct: 906  KKVSPISLRVQKQLTTDTGLKEIA------PK-----------GEL----GDPL-----P 939

Query: 534  CYEEMIGFRDIEHLQLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLR 593
             + EM  F ++E+L+LS      +I   Q   +S  +NL  L+V+ C N+     ++L++
Sbjct: 940  LFNEMFCFPNLENLELSSIA-CEKICDDQLSAIS--SNLMSLIVERCWNLKYLFTSSLVK 996

Query: 594  CFNNLVLLEVRNCDSLEEVLHLEELNADKEHIGPLFLELSLLGLIDLPKLKRFCNFTGNI 653
                L  LEV +C S+E ++  EEL  ++ +   LF EL  L L +LP + RFC+  G  
Sbjct: 997  NLLLLKRLEVFDCMSVEGIIVAEELVEEERNRKKLFPELDFLKLKNLPHITRFCD--GYP 1054

Query: 654  IEMPVLCSLAIENCTDMETFISNSVVHATTDNKEPQKLTSEENFLLVHQVQPLFNEKVG 712
            +E   L  L IENC  +  F+S S      +++E + + SE+N     + QPLFNEKV 
Sbjct: 1055 VEFSSLRKLLIENCPALNMFVSKSPSADMIESREAKGMNSEKNHH--TETQPLFNEKVA 1111




Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111296|ref|XP_002332952.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222834264|gb|EEE72741.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|359488288|ref|XP_003633735.1| PREDICTED: LOW QUALITY PROTEIN: probable disease resistance protein At1g61310-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|255542484|ref|XP_002512305.1| phosphoprotein phosphatase, putative [Ricinus communis] gi|223548266|gb|EEF49757.1| phosphoprotein phosphatase, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|359488027|ref|XP_002269288.2| PREDICTED: disease resistance protein At4g27190-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|255574526|ref|XP_002528174.1| Disease resistance protein RFL1, putative [Ricinus communis] gi|223532386|gb|EEF34181.1| Disease resistance protein RFL1, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|224111284|ref|XP_002332949.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222834261|gb|EEE72738.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|224110992|ref|XP_002332999.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222834484|gb|EEE72961.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|224143316|ref|XP_002336027.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222838884|gb|EEE77235.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|296087872|emb|CBI35155.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query829
TAIR|locus:2136447985 AT4G27190 [Arabidopsis thalian 0.439 0.369 0.273 7.6e-20
TAIR|locus:2131689919 AT4G27220 [Arabidopsis thalian 0.425 0.384 0.254 2.5e-19
TAIR|locus:22058041556 AT1G27180 [Arabidopsis thalian 0.143 0.076 0.377 1.7e-08
TAIR|locus:22058241384 AT1G27170 [Arabidopsis thalian 0.121 0.072 0.398 2.1e-08
ZFIN|ZDB-GENE-040718-372238 lrrc57 "leucine rich repeat co 0.174 0.609 0.296 5.7e-08
TAIR|locus:21634261187 TAO1 "target of AVRB operation 0.300 0.209 0.258 2.6e-07
TAIR|locus:20534051215 AT2G14080 [Arabidopsis thalian 0.312 0.213 0.264 1.3e-06
TAIR|locus:2094498 1981 AT3G25510 [Arabidopsis thalian 0.499 0.208 0.243 1.7e-06
TAIR|locus:21171491201 AT4G19050 [Arabidopsis thalian 0.436 0.301 0.235 2.3e-06
MGI|MGI:2676665 1490 Lrrc7 "leucine rich repeat con 0.297 0.165 0.278 4.5e-06
TAIR|locus:2136447 AT4G27190 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 282 (104.3 bits), Expect = 7.6e-20, Sum P(2) = 7.6e-20
 Identities = 108/395 (27%), Positives = 189/395 (47%)

Query:    16 ETIRKDPIA-----ISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTE 70
             + IR+D +A     +SL    ++ LP+ ++   ++  +L+ +G   +  ++   F +   
Sbjct:   492 QDIRQDKLAPSLRRVSLMNNKLESLPDLVEEFCVKTSVLLLQGNFLLK-EVPIGFLQAFP 550

Query:    71 ELKVLSLIGIHFSSLPS-SLGRLINLQTLCLDWC-QLEDVAAIGQLKKLEILSFRGSDIK 128
              L++L+L G    S PS SL RL +L +L L  C +L  + ++  L KLE+L   G+ I 
Sbjct:   551 TLRILNLSGTRIKSFPSCSLLRLFSLHSLFLRDCFKLVKLPSLETLAKLELLDLCGTHIL 610

Query:   129 QLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSN--- 185
             + P  + +L R + LDLS    L  I   V+S+ S LE L M  S  +W  V+G +    
Sbjct:   611 EFPRGLEELKRFRHLDLSRTLHLESIPARVVSRLSSLETLDMTSSHYRWS-VQGETQKGQ 669

Query:   186 ASLAELKGLSKLTTLEIHVWDAQIL---PQDWVSVELQRYKICIGEARRIWPVNSETSRL 242
             A++ E+  L +L  L I +  +  L      W+   L+++++ +G +R I     +  RL
Sbjct:   670 ATVEEIGCLQRLQVLSIRLHSSPFLLNKRNTWIK-RLKKFQLVVG-SRYILRTRHDKRRL 727

Query:   243 VWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHEL-DDGEGFPRLKHLWVER 301
                H   NVS +  + G   LL     + L   +G++ ++ +L  D +GF  LK L +E 
Sbjct:   728 TISH--LNVSQV--SIGW--LLAYTTSLALNHCQGIEAMMKKLVSDNKGFKNLKSLTIEN 781

Query:   302 C-----SEILHIVGSVGRVRCTIFPLLESLSLWFLS--NLETICDSQLTEDQSFSNLRII 354
                   S +  +  +  +    I  LL +L    L   +LET  + Q         L+II
Sbjct:   782 VIINTNSWVEMVSTNTSKQSSDILDLLPNLEELHLRRVDLETFSELQTHLGLKLETLKII 841

Query:   355 EVKSCDKLKHLFSFSMAKNLLRLQKVEVFFCDDLE 389
             E+  C KL+ L        +  L+++E+ +CD L+
Sbjct:   842 EITMCRKLRTLLDKRNFLTIPNLEEIEISYCDSLQ 876


GO:0000166 "nucleotide binding" evidence=IEA
GO:0005739 "mitochondrion" evidence=ISM
GO:0006952 "defense response" evidence=IEA;ISS
GO:0017111 "nucleoside-triphosphatase activity" evidence=IEA
GO:0043531 "ADP binding" evidence=IEA
TAIR|locus:2131689 AT4G27220 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2205804 AT1G27180 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2205824 AT1G27170 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-040718-372 lrrc57 "leucine rich repeat containing 57" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
TAIR|locus:2163426 TAO1 "target of AVRB operation1" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2053405 AT2G14080 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2094498 AT3G25510 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2117149 AT4G19050 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
MGI|MGI:2676665 Lrrc7 "leucine rich repeat containing 7" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Your Input:
eugene3.03110007
cc-nbs-lrr resistance protein (1315 aa)
(Populus trichocarpa)
Predicted Functional Partners:
 
Sorry, there are no predicted associations at the current settings.
 

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query829
COG4886394 COG4886, COG4886, Leucine-rich repeat (LRR) protei 2e-06
PLN032101153 PLN03210, PLN03210, Resistant to P 0.001
pfam1279943 pfam12799, LRR_4, Leucine Rich repeats (2 copies) 0.003
>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 38/111 (34%), Positives = 49/111 (44%), Gaps = 3/111 (2%)

Query: 60  QISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAA-IGQLKKLE 118
            I  L       LK L L      SLPS L  L NL+ L L +  L D+   +  L  L 
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLN 189

Query: 119 ILSFRGSDIKQLPLEIGQLTRLQLLDLSNCSSLVVIAPNVISKFSRLEELY 169
            L   G+ I  LP EI  L+ L+ LDLSN S + +   + +S    L  L 
Sbjct: 190 NLDLSGNKISDLPPEIELLSALEELDLSNNSIIEL--LSSLSNLKNLSGLE 238


Length = 394

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P Back     alignment and domain information
>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 829
PLN00113968 leucine-rich repeat receptor-like protein kinase; 100.0
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.97
PLN032101153 Resistant to P. syringae 6; Provisional 99.87
PLN032101153 Resistant to P. syringae 6; Provisional 99.87
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.77
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.77
KOG4194873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.76
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.75
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.73
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.71
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 99.69
KOG4194873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.69
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.68
KOG0617264 consensus Ras suppressor protein (contains leucine 99.65
KOG0617264 consensus Ras suppressor protein (contains leucine 99.57
KOG4341483 consensus F-box protein containing LRR [General fu 99.39
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 99.34
KOG4341483 consensus F-box protein containing LRR [General fu 99.34
PRK15370754 E3 ubiquitin-protein ligase SlrP; Provisional 99.34
PRK15387788 E3 ubiquitin-protein ligase SspH2; Provisional 99.33
PRK15370754 E3 ubiquitin-protein ligase SlrP; Provisional 99.32
PRK15387788 E3 ubiquitin-protein ligase SspH2; Provisional 99.27
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.12
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.11
KOG4237498 consensus Extracellular matrix protein slit, conta 99.09
KOG0532722 consensus Leucine-rich repeat (LRR) protein, conta 99.03
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.02
KOG4237498 consensus Extracellular matrix protein slit, conta 98.95
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 98.93
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.92
KOG0532722 consensus Leucine-rich repeat (LRR) protein, conta 98.88
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.86
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.76
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.72
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.63
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.57
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.36
PRK15386 426 type III secretion protein GogB; Provisional 98.33
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 98.32
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.3
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.27
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 98.27
PRK15386 426 type III secretion protein GogB; Provisional 98.25
PLN03150623 hypothetical protein; Provisional 98.22
PLN03150623 hypothetical protein; Provisional 98.2
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 98.19
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.14
KOG3665699 consensus ZYG-1-like serine/threonine protein kina 98.09
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 98.01
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 97.98
KOG1947482 consensus Leucine rich repeat proteins, some prote 97.96
KOG1947482 consensus Leucine rich repeat proteins, some prote 97.92
KOG3665699 consensus ZYG-1-like serine/threonine protein kina 97.89
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.79
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.78
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 97.67
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 97.58
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 97.53
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.48
KOG2982418 consensus Uncharacterized conserved protein [Funct 97.28
KOG2982418 consensus Uncharacterized conserved protein [Funct 97.27
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.18
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 97.1
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.57
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 96.52
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.38
KOG2123388 consensus Uncharacterized conserved protein [Funct 96.33
KOG3864221 consensus Uncharacterized conserved protein [Funct 95.88
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 95.66
KOG2123388 consensus Uncharacterized conserved protein [Funct 95.5
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 95.43
KOG3864221 consensus Uncharacterized conserved protein [Funct 95.0
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 94.43
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 94.27
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 92.66
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 91.74
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 86.93
smart0037026 LRR Leucine-rich repeats, outliers. 86.93
KOG0473326 consensus Leucine-rich repeat protein [Function un 85.37
KOG0473326 consensus Leucine-rich repeat protein [Function un 83.2
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 82.22
smart0037026 LRR Leucine-rich repeats, outliers. 81.95
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 81.95
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 80.14
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
Probab=100.00  E-value=3.7e-32  Score=334.62  Aligned_cols=204  Identities=24%  Similarity=0.356  Sum_probs=168.2

Q ss_pred             cccCCccccCC--CCCCcEEEcCCCCCCC-CCCcc-CCCCCcEEEeecCCCcccccccchhhhcCCCCccEEEecCCCCC
Q 003328            8 ADVEKKMEETI--RKDPIAISLPQRDIQE-LPERL-QCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFS   83 (829)
Q Consensus         8 ~~~~~~~~~~~--~~~l~~L~l~~~~~~~-l~~~~-~~~~Lr~L~l~~~~~~~~~~~lp~~~~~~l~~Lr~L~L~~~~i~   83 (829)
                      .+.+.|.++..  ..+++.|+++++.+.. ++..+ .+++|++|++++|.   ....+|..+|.++++||+|++++|.+.
T Consensus        55 ~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~---~~~~ip~~~~~~l~~L~~L~Ls~n~l~  131 (968)
T PLN00113         55 ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ---LSGPIPDDIFTTSSSLRYLNLSNNNFT  131 (968)
T ss_pred             CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc---cCCcCChHHhccCCCCCEEECcCCccc
Confidence            46788988753  4689999999998874 44444 89999999999998   456899988889999999999999987


Q ss_pred             C-CchhhcCCCCCcEEEccccCCC-Cc-ccccCCCCCcEEEccCCCCc-cchhhhcCCCCCCEEeccCCCCCCccChhhh
Q 003328           84 S-LPSSLGRLINLQTLCLDWCQLE-DV-AAIGQLKKLEILSFRGSDIK-QLPLEIGQLTRLQLLDLSNCSSLVVIAPNVI  159 (829)
Q Consensus        84 ~-lp~~l~~l~~Lr~L~L~~~~l~-~l-~~i~~L~~L~~L~l~~~~l~-~lp~~i~~L~~L~~L~l~~~~~l~~lp~~~l  159 (829)
                      . +|.  +.+++|++|++++|.+. .+ ..++++.+|++|++++|.+. .+|..++++++|++|++++|...+.+|.. +
T Consensus       132 ~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-l  208 (968)
T PLN00113        132 GSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRE-L  208 (968)
T ss_pred             cccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChH-H
Confidence            5 554  57899999999999987 44 78999999999999999876 78999999999999999999866778887 9


Q ss_pred             cCCCcccEEEccCCccccccccCCCccchhhhcCCCCCcEEEeecCCCC-CcCCcc-ccccccEEEEE
Q 003328          160 SKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQ-ILPQDW-VSVELQRYKIC  225 (829)
Q Consensus       160 ~~L~~L~~L~l~~~~~~~~~~~~~~~~~~~~L~~l~~L~~L~l~~~~~~-~~~~~~-~~~~L~~L~l~  225 (829)
                      +++++|++|++++|.+.        ......++++++|+.|++++|... .+|..+ .+++|+.|++.
T Consensus       209 ~~l~~L~~L~L~~n~l~--------~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  268 (968)
T PLN00113        209 GQMKSLKWIYLGYNNLS--------GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLY  268 (968)
T ss_pred             cCcCCccEEECcCCccC--------CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECc
Confidence            99999999999998765        234456778899999999988765 344433 56677777664



>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>KOG0473 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0473 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

No homologous structure with e-value below 0.005

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query829
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 3e-17
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 5e-17
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 1e-12
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 2e-12
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 1e-16
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 4e-16
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 1e-15
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 8e-05
4ezg_A197 Putative uncharacterized protein; internalin-A, le 6e-13
4ezg_A197 Putative uncharacterized protein; internalin-A, le 2e-11
4ezg_A197 Putative uncharacterized protein; internalin-A, le 2e-07
4ezg_A197 Putative uncharacterized protein; internalin-A, le 7e-05
4fmz_A347 Internalin; leucine rich repeat, structural genomi 3e-12
4fmz_A347 Internalin; leucine rich repeat, structural genomi 1e-11
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-11
4fmz_A347 Internalin; leucine rich repeat, structural genomi 7e-09
4fmz_A347 Internalin; leucine rich repeat, structural genomi 1e-08
4fmz_A347 Internalin; leucine rich repeat, structural genomi 3e-04
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 5e-12
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 5e-10
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 9e-08
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 3e-04
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-11
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-11
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-09
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-09
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 3e-08
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-06
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-06
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-05
1o6v_A466 Internalin A; bacterial infection, extracellular r 6e-11
1o6v_A466 Internalin A; bacterial infection, extracellular r 2e-10
1o6v_A466 Internalin A; bacterial infection, extracellular r 2e-09
1o6v_A466 Internalin A; bacterial infection, extracellular r 2e-09
1o6v_A466 Internalin A; bacterial infection, extracellular r 1e-07
1o6v_A466 Internalin A; bacterial infection, extracellular r 2e-07
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 1e-10
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 5e-06
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 1e-05
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-10
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-08
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-07
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 4e-07
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 8e-07
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-06
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 4e-10
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 1e-07
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 1e-04
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 5e-10
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 3e-08
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 8e-08
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-04
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 6e-10
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 3e-08
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 2e-05
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-09
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-07
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 6e-05
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 2e-09
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 7e-08
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 1e-07
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 2e-07
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 2e-07
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 6e-07
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-09
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 4e-09
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-09
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-07
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 7e-07
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 5e-06
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 8e-06
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 3e-09
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 8e-07
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 3e-09
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 1e-08
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 4e-08
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 4e-08
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 6e-08
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 7e-08
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 2e-07
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 3e-05
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 5e-09
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 7e-09
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 6e-09
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 6e-09
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 8e-08
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-07
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 3e-07
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-06
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 8e-09
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 3e-06
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 8e-06
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 1e-05
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 9e-09
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-08
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-07
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 4e-07
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-06
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-06
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 3e-06
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 2e-04
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 1e-08
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 1e-08
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 1e-08
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 4e-08
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 2e-08
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 2e-07
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 2e-06
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 3e-08
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 2e-07
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 4e-08
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 1e-06
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 9e-06
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 4e-08
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 5e-08
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 3e-06
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 3e-05
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 8e-08
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 5e-06
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 9e-06
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 4e-05
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-04
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 3e-04
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 1e-07
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 9e-07
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 1e-04
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 1e-07
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 6e-05
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-07
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 5e-06
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 2e-07
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 6e-07
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 2e-05
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 2e-07
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 5e-07
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 4e-06
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 3e-07
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 4e-07
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 4e-06
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 2e-05
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 6e-04
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 3e-07
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 4e-07
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 5e-04
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 5e-07
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 1e-06
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 2e-04
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 5e-04
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 1e-06
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 2e-06
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 2e-06
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 4e-06
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 8e-06
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-05
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 3e-05
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-04
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-04
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 1e-05
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 2e-04
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 2e-05
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 9e-05
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 2e-04
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 3e-05
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 3e-05
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 8e-05
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 6e-04
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 1e-04
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 2e-04
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 6e-04
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 2e-04
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 3e-04
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 6e-04
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 3e-04
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 3e-04
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 3e-04
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 4e-04
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 4e-04
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query829
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 100.0
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.97
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.97
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.97
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 99.96
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 99.96
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.96
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.95
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.95
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.95
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.94
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.94
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.94
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.93
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.92
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.92
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.92
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.92
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.91
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.91
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.91
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.9
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.9
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.89
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.89
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.89
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.88
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.88
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.88
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 99.87
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.86
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 99.86
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.85
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.84
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.84
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.84
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.83
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.82
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.82
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.81
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.81
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.8
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.8
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.8
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.79
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.79
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.77
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.77
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.77
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.76
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.76
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.76
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.76
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.76
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.75
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.74
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.74
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.73
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.73
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.73
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.73
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.73
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.72
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.72
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.71
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.7
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.7
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.7
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.69
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.68
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.68
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.67
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.66
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.66
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.64
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.64
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.64
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.63
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 99.61
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.61
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.6
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.6
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.6
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.6
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.6
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.59
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.59
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.58
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.57
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.57
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.57
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.56
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.56
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.54
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.54
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 99.53
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.53
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.53
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.51
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.51
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.5
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 99.49
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.49
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.47
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.46
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.46
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.44
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.44
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 99.43
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.41
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.4
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.39
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.37
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.37
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.35
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 99.35
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.35
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.33
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.32
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.31
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.31
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 99.27
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.21
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.2
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.19
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.18
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.14
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 99.1
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 99.07
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 99.07
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 99.06
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.97
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 98.81
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.75
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 98.73
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.65
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.6
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.49
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.48
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.18
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 98.16
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.1
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 98.07
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 98.04
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 98.01
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 97.93
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 97.77
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.64
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.3
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.3
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.22
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 95.66
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 95.44
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 94.81
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 94.34
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 94.29
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 94.15
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
Probab=100.00  E-value=2.3e-35  Score=352.36  Aligned_cols=500  Identities=15%  Similarity=0.059  Sum_probs=338.6

Q ss_pred             cccCCccccCC-CCCCcEEEcCCCCCCC----CCCcc-CCCCCcEEEeecCCCcccccccchhhhcCCCCccEEEecCCC
Q 003328            8 ADVEKKMEETI-RKDPIAISLPQRDIQE----LPERL-QCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIH   81 (829)
Q Consensus         8 ~~~~~~~~~~~-~~~l~~L~l~~~~~~~----l~~~~-~~~~Lr~L~l~~~~~~~~~~~lp~~~~~~l~~Lr~L~L~~~~   81 (829)
                      .+.+.|.+|.. ..+++.|+++++.+..    +++.+ ++++|+.++++.+.    +..+|.. |+++++||+|++++|.
T Consensus        37 ~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~----~~~l~~~-~~~l~~L~~L~Ls~n~  111 (768)
T 3rgz_A           37 KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSH----INGSVSG-FKCSASLTSLDLSRNS  111 (768)
T ss_dssp             SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSC----EEECCCC-CCCCTTCCEEECCSSE
T ss_pred             CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCC----cCCCchh-hccCCCCCEEECCCCc
Confidence            46788988853 5689999999998874    66554 78889999988887    4455665 5899999999999999


Q ss_pred             CCC-Cch--hhcCCCCCcEEEccccCCCCc---ccccCCCCCcEEEccCCCCccc-hhh---hcCCCCCCEEeccCCCCC
Q 003328           82 FSS-LPS--SLGRLINLQTLCLDWCQLEDV---AAIGQLKKLEILSFRGSDIKQL-PLE---IGQLTRLQLLDLSNCSSL  151 (829)
Q Consensus        82 i~~-lp~--~l~~l~~Lr~L~L~~~~l~~l---~~i~~L~~L~~L~l~~~~l~~l-p~~---i~~L~~L~~L~l~~~~~l  151 (829)
                      +.. +|.  .++++++||+|++++|.+...   ..+.++++|++|++++|.++.. |..   ++++++|++|++++|...
T Consensus       112 l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~  191 (768)
T 3rgz_A          112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS  191 (768)
T ss_dssp             EEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEE
T ss_pred             CCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCccc
Confidence            875 777  899999999999999987633   3348999999999999999855 444   789999999999998743


Q ss_pred             CccChhhhcCCCcccEEEccCCccccccccCCCccchhhhcCCCCCcEEEeecCCCCC-cCCcc-ccccccEEEEEEccc
Q 003328          152 VVIAPNVISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQI-LPQDW-VSVELQRYKICIGEA  229 (829)
Q Consensus       152 ~~lp~~~l~~L~~L~~L~l~~~~~~~~~~~~~~~~~~~~L~~l~~L~~L~l~~~~~~~-~~~~~-~~~~L~~L~l~~~~~  229 (829)
                      +..+   .+++++|++|++++|.+.     +    .+..++++++|++|+++++.+.. ++..+ .+++|+.|+++.+..
T Consensus       192 ~~~~---~~~l~~L~~L~Ls~n~l~-----~----~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l  259 (768)
T 3rgz_A          192 GDVD---VSRCVNLEFLDVSSNNFS-----T----GIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF  259 (768)
T ss_dssp             SCCB---CTTCTTCCEEECCSSCCC-----S----CCCBCTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCC
T ss_pred             ccCC---cccCCcCCEEECcCCcCC-----C----CCcccccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcc
Confidence            3333   588999999999999775     1    22337888999999999998763 33333 678889888764432


Q ss_pred             cccCCCCCCCccEEEeccCCccccchhhhhHHHhhhhheeEeeccccCccccccccCCCCCCCCCcEEEEeecCCceEEe
Q 003328          230 RRIWPVNSETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIV  309 (829)
Q Consensus       230 ~~~w~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~l~~L~~L~L~~~~~~~~~~~~l~~~~~~~~L~~L~l~~~~~l~~i~  309 (829)
                      .. .                     ++..    .+++|++|++.++.-...+...+.  ..+++|++|+++++.-...+ 
T Consensus       260 ~~-~---------------------~~~~----~l~~L~~L~L~~n~l~~~ip~~~~--~~~~~L~~L~Ls~n~l~~~~-  310 (768)
T 3rgz_A          260 VG-P---------------------IPPL----PLKSLQYLSLAENKFTGEIPDFLS--GACDTLTGLDLSGNHFYGAV-  310 (768)
T ss_dssp             EE-S---------------------CCCC----CCTTCCEEECCSSEEEESCCCCSC--TTCTTCSEEECCSSEEEECC-
T ss_pred             cC-c---------------------cCcc----ccCCCCEEECcCCccCCccCHHHH--hhcCcCCEEECcCCcCCCcc-
Confidence            11 0                     0000    147888888888754333333332  23489999999888632221 


Q ss_pred             cccCcccccccccccceeccccccchhhhcCCCCCCCCCCCccEEEEecCCCCccccchHHHHhhc-ccceEEEecccCc
Q 003328          310 GSVGRVRCTIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLL-RLQKVEVFFCDDL  388 (829)
Q Consensus       310 ~~~~~~~~~~~~~L~~L~L~~~~~l~~~~~~~l~~~~~~~~L~~L~i~~C~~L~~l~~~~~~~~l~-~L~~L~i~~c~~l  388 (829)
                        +  .....+++|+.|++.++.-...+...   ..+.+++|++|++.+|.--..+|.  .+..++ +|+.|+++++.--
T Consensus       311 --p--~~~~~l~~L~~L~L~~n~l~~~ip~~---~l~~l~~L~~L~Ls~n~l~~~~p~--~l~~l~~~L~~L~Ls~N~l~  381 (768)
T 3rgz_A          311 --P--PFFGSCSLLESLALSSNNFSGELPMD---TLLKMRGLKVLDLSFNEFSGELPE--SLTNLSASLLTLDLSSNNFS  381 (768)
T ss_dssp             --C--GGGGGCTTCCEEECCSSEEEEECCHH---HHTTCTTCCEEECCSSEEEECCCT--THHHHTTTCSEEECCSSEEE
T ss_pred             --c--hHHhcCCCccEEECCCCcccCcCCHH---HHhcCCCCCEEeCcCCccCccccH--HHHhhhcCCcEEEccCCCcC
Confidence              1  12356788999999887643221110   035788999999988853324442  244555 8999999887532


Q ss_pred             ceecccCCCCCCCcccccccccCCCCCCCCCCCCceeeeeeccCcchhhHHhhhcccccccccccCccceEeeccCCCcc
Q 003328          389 EMMVGPDREKPTTSLGFNEITADDDAAPKVGIPGILVNLNVSRCDKIEEIIRHVGEEVKENRIAFGKLKVLILNYLPTLT  468 (829)
Q Consensus       389 ~~~~~~~~~~~~~~l~~~~i~~~~~~~~~~~~~~~L~~L~i~~C~~L~~l~~~~~~~~~~~~~~~~~L~~L~l~~c~~L~  468 (829)
                      ..++.. ..                    ....+.|+.|++++|.-...+        +..+..+++|+.|++.++.--.
T Consensus       382 ~~~~~~-~~--------------------~~~~~~L~~L~L~~n~l~~~~--------p~~l~~l~~L~~L~Ls~N~l~~  432 (768)
T 3rgz_A          382 GPILPN-LC--------------------QNPKNTLQELYLQNNGFTGKI--------PPTLSNCSELVSLHLSFNYLSG  432 (768)
T ss_dssp             EECCTT-TT--------------------CSTTCCCCEEECCSSEEEEEC--------CGGGGGCTTCCEEECCSSEEES
T ss_pred             CCcChh-hh--------------------hcccCCccEEECCCCcccccc--------CHHHhcCCCCCEEECcCCcccC
Confidence            222211 11                    011457888888888644333        4456778899999998884332


Q ss_pred             eeecCCccccCCCccEEeeccCCCcceecccccCCCCCccceee-cccccccccccCCCccchhhhhhhhccccCCcceE
Q 003328          469 SFCLENYTLEFPSLERVSLTHCPNMKTFSHRILSIPKPCKVQVT-EKEEGELHHWEGNNLNSTIQKCYEEMIGFRDIEHL  547 (829)
Q Consensus       469 ~~~~~~~~~~~~~L~~L~i~~C~~l~~~~~~~~~~~l~~~L~~L-i~~c~~l~~~~~~~~~~~~~~~l~~~~~~~~L~~L  547 (829)
                      ..+.  ....+++|+.|++++|.-...+|..+  ..++. |+.| +.+|.-....+         .   .+..+++|+.|
T Consensus       433 ~~p~--~l~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~-L~~L~L~~N~l~~~~p---------~---~l~~l~~L~~L  495 (768)
T 3rgz_A          433 TIPS--SLGSLSKLRDLKLWLNMLEGEIPQEL--MYVKT-LETLILDFNDLTGEIP---------S---GLSNCTNLNWI  495 (768)
T ss_dssp             CCCG--GGGGCTTCCEEECCSSCCCSCCCGGG--GGCTT-CCEEECCSSCCCSCCC---------G---GGGGCTTCCEE
T ss_pred             cccH--HHhcCCCCCEEECCCCcccCcCCHHH--cCCCC-ceEEEecCCcccCcCC---------H---HHhcCCCCCEE
Confidence            3332  23478899999999986444454321  23455 8888 77774321111         1   12337889999


Q ss_pred             EeccCCCceeeccCCCCCCCcCCCCcEEEEecCCCCccccchhhHHhccCCcEEEEecCcchhhhhc
Q 003328          548 QLSHFPRLREIWHGQALPVSFFNNLSDLVVDDCTNMSSAIPANLLRCFNNLVLLEVRNCDSLEEVLH  614 (829)
Q Consensus       548 ~l~~c~~l~~~~~~~~~~~~~l~~L~~L~i~~C~~L~~~~p~~~~~~l~sL~~L~i~~C~~L~~l~~  614 (829)
                      +++++.-...+    +..+..+++|+.|++++|.-... +|..+ ..+++|+.|++++|+-...+|.
T Consensus       496 ~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~-~p~~l-~~l~~L~~L~Ls~N~l~g~ip~  556 (768)
T 3rgz_A          496 SLSNNRLTGEI----PKWIGRLENLAILKLSNNSFSGN-IPAEL-GDCRSLIWLDLNTNLFNGTIPA  556 (768)
T ss_dssp             ECCSSCCCSCC----CGGGGGCTTCCEEECCSSCCEEE-CCGGG-GGCTTCCEEECCSSEEESBCCG
T ss_pred             EccCCccCCcC----ChHHhcCCCCCEEECCCCcccCc-CCHHH-cCCCCCCEEECCCCccCCcCCh
Confidence            99887633233    22344568899999999865543 56554 5889999999998874444443



>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 829
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 3e-08
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 7e-04
d2astb2284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 7e-06
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 7e-05
d1m9la_198 c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree 6e-04
d1dcea3124 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase 8e-04
d1dcea3124 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase 0.001
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.001
d1koha1162 c.10.2.3 (A:201-362) mRNA export factor tap {Human 0.002
d1h6ta2210 c.10.2.1 (A:31-240) Internalin B {Listeria monocyt 0.004
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]
 Score = 54.6 bits (130), Expect = 3e-08
 Identities = 20/76 (26%), Positives = 35/76 (46%), Gaps = 2/76 (2%)

Query: 72  LKVLSLIGIHFSSLPSSLGRLINLQTLCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLP 131
           L  L+L   + S +   +  L  LQ L     ++ DV+++  L  +  LS   + I  L 
Sbjct: 309 LTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLT 367

Query: 132 LEIGQLTRLQLLDLSN 147
             +  LTR+  L L++
Sbjct: 368 -PLANLTRITQLGLND 382


>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query829
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.78
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.74
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.69
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.66
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.64
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.64
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.64
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.64
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.62
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.62
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.61
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.61
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.6
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.58
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.57
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.56
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.51
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.48
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.47
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.41
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.39
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.38
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.37
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.29
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.26
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.25
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.22
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.22
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.16
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.03
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.81
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.8
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 98.77
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.62
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 98.59
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.57
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 97.61
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 97.57
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 97.18
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 97.04
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 96.8
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 96.48
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78  E-value=9.4e-18  Score=180.92  Aligned_cols=300  Identities=18%  Similarity=0.181  Sum_probs=177.1

Q ss_pred             CCCCCcEEEcCCCCCCCCCCccCCCCCcEEEeecCCCcccccccchhhhcCCCCccEEEecCCCCCCCchhhcCCCCCcE
Q 003328           18 IRKDPIAISLPQRDIQELPERLQCPNLQLFLLITKGIAPVSMQISDLFFEGTEELKVLSLIGIHFSSLPSSLGRLINLQT   97 (829)
Q Consensus        18 ~~~~l~~L~l~~~~~~~l~~~~~~~~Lr~L~l~~~~~~~~~~~lp~~~~~~l~~Lr~L~L~~~~i~~lp~~l~~l~~Lr~   97 (829)
                      .++++++|++++++|+.+.....+++|++|++++|.    +..++.  |+++++|++|++++|++..++ .++.+++|++
T Consensus        42 ~l~~l~~L~l~~~~I~~l~gl~~L~nL~~L~Ls~N~----l~~l~~--l~~L~~L~~L~L~~n~i~~i~-~l~~l~~L~~  114 (384)
T d2omza2          42 DLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQ----LTDITP--LKNLTKLVDILMNNNQIADIT-PLANLTNLTG  114 (384)
T ss_dssp             HHTTCCEEECCSSCCCCCTTGGGCTTCCEEECCSSC----CCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCE
T ss_pred             HhCCCCEEECCCCCCCCccccccCCCCCEEeCcCCc----CCCCcc--ccCCccccccccccccccccc-cccccccccc
Confidence            456899999999999888655588999999999998    677775  689999999999999998876 4889999999


Q ss_pred             EEccccCCCCcccccCCCCCcEEEccCCCCccch--------------------hhhcCCCCCCEEeccCCCCCCccChh
Q 003328           98 LCLDWCQLEDVAAIGQLKKLEILSFRGSDIKQLP--------------------LEIGQLTRLQLLDLSNCSSLVVIAPN  157 (829)
Q Consensus        98 L~L~~~~l~~l~~i~~L~~L~~L~l~~~~l~~lp--------------------~~i~~L~~L~~L~l~~~~~l~~lp~~  157 (829)
                      |+++++.+..+........+..+....+.+..+.                    ..+.............+.  ......
T Consensus       115 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  192 (384)
T d2omza2         115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISV  192 (384)
T ss_dssp             EECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSC--CCCCGG
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccc--cccccc
Confidence            9999888877755555666666665554332211                    112222333333333322  111222


Q ss_pred             hhcCCCcccEEEccCCccccccccCCCccchhhhcCCCCCcEEEeecCCCCCcCCccccccccEEEEEEccccccCCCCC
Q 003328          158 VISKFSRLEELYMGDSFSQWDKVEGGSNASLAELKGLSKLTTLEIHVWDAQILPQDWVSVELQRYKICIGEARRIWPVNS  237 (829)
Q Consensus       158 ~l~~L~~L~~L~l~~~~~~~~~~~~~~~~~~~~L~~l~~L~~L~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~w~~~~  237 (829)
                       ...+++++.++++++.+.          .+......++|+.|++.++.+..++....+++|+.+++..+...       
T Consensus       193 -~~~l~~~~~l~l~~n~i~----------~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~-------  254 (384)
T d2omza2         193 -LAKLTNLESLIATNNQIS----------DITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQIS-------  254 (384)
T ss_dssp             -GGGCTTCSEEECCSSCCC----------CCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC-------
T ss_pred             -cccccccceeeccCCccC----------CCCcccccCCCCEEECCCCCCCCcchhhcccccchhccccCccC-------
Confidence             566677777777666543          12223445667777777776666554445566666655322110       


Q ss_pred             CCccEEEeccCCccccchhhhhHHHhhhhheeEeeccccCccccccccCCCCCCCCCcEEEEeecCCceEEecccCcccc
Q 003328          238 ETSRLVWLHGLENVSTLLENYGMKMLLKEAEEIHLIKLKGVQNVVHELDDGEGFPRLKHLWVERCSEILHIVGSVGRVRC  317 (829)
Q Consensus       238 ~~~~~~~l~~~~~~~~~l~~~~~~~~l~~L~~L~L~~~~~~~~~~~~l~~~~~~~~L~~L~l~~~~~l~~i~~~~~~~~~  317 (829)
                                      .+..   -..+++|++|++.++. +..+ ..   +..++.++.+.+.++.- +.+      ...
T Consensus       255 ----------------~~~~---~~~~~~L~~L~l~~~~-l~~~-~~---~~~~~~l~~l~~~~n~l-~~~------~~~  303 (384)
T d2omza2         255 ----------------NLAP---LSGLTKLTELKLGANQ-ISNI-SP---LAGLTALTNLELNENQL-EDI------SPI  303 (384)
T ss_dssp             ----------------CCGG---GTTCTTCSEEECCSSC-CCCC-GG---GTTCTTCSEEECCSSCC-SCC------GGG
T ss_pred             ----------------CCCc---ccccccCCEeeccCcc-cCCC-Cc---ccccccccccccccccc-ccc------ccc
Confidence                            0000   0012455555554442 1111 11   23566666666665531 111      123


Q ss_pred             cccccccceeccccccchhhhcCCCCCCCCCCCccEEEEecCCCCccccchHHHHhhcccceEEEecc
Q 003328          318 TIFPLLESLSLWFLSNLETICDSQLTEDQSFSNLRIIEVKSCDKLKHLFSFSMAKNLLRLQKVEVFFC  385 (829)
Q Consensus       318 ~~~~~L~~L~L~~~~~l~~~~~~~l~~~~~~~~L~~L~i~~C~~L~~l~~~~~~~~l~~L~~L~i~~c  385 (829)
                      ..+++++.|+++++ +++.     +++...+++|++|++++| ++++++.   +..+++|++|+++++
T Consensus       304 ~~~~~l~~L~ls~n-~l~~-----l~~l~~l~~L~~L~L~~n-~l~~l~~---l~~l~~L~~L~l~~N  361 (384)
T d2omza2         304 SNLKNLTYLTLYFN-NISD-----ISPVSSLTKLQRLFFANN-KVSDVSS---LANLTNINWLSAGHN  361 (384)
T ss_dssp             GGCTTCSEEECCSS-CCSC-----CGGGGGCTTCCEEECCSS-CCCCCGG---GGGCTTCCEEECCSS
T ss_pred             chhcccCeEECCCC-CCCC-----CcccccCCCCCEEECCCC-CCCCChh---HcCCCCCCEEECCCC
Confidence            44566666666655 2222     222456777777777776 5666542   355677777777665



>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure